RCC-THV is concerned with the safety and health conditions of people affected by HIV, TB and viral hepatitis during the COVID-19 pandemic.

COVID-19-related service disruptions could cause hundreds of thousands of extra deaths from AIDS-related illnesses, including from TB.

6.3 million more people ill with TB and 1.4 million more TB deaths by 2025; Length of quarantine, movement restrictions and disruption of TB services could spell disaster for hundreds of thousands at risk.

Advocates call for a higher level of global coordination, transparency, and accountability to ensure sustainable and equitable access to testing.

Cutting global health funding in the middle of a pandemic will only prolong the devastating loss of life and economic damage in the U.S. and across the world, and undermine the response to other infectious diseases, including HIV, TB, and hepatitis C.

More research required to determine if century-old TB vaccine protects against SARS-CoV-2 infection or severe COVID-19 disease.

Advocates request Cepheid immediately reduce the price of Xpert tests to $5, inclusive of service and maintenance; Cepheid claims costs for each Xpert cartridge "substantially exceed" the requested price target of $5, but does not provide evidence to support this claim.

Cepheid is profiteering during a pandemic, with dangerous consequences for countries with vulnerable populations and health systems.

Join the virtual - worldwide - TB town hall on 24 March!

WHO advocacy and communications package to support awareness building and drive action across all levels, in the lead up to and on World TB Day.